Bo Jin

Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial

Baohui Han, Bo Jin, Tianqing Chu et al. · International Journal of Cancer · 2017 · 153 citations · Full text

Medicine, Oncology, Pharmacology +12

Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma

Fangfei Qian, Wenjia Yang, Rui Wang et al. · Journal of Thoracic and Cardiovascular Surgery · 2017 · 106 citations · Full text

Medicine, Oncology, Surgery +17

EGFR tyrosine kinase inhibitor (TKI) in patients with advanced non-small cell lung cancer (NSCLC) harboring uncommon EGFR mutations: A real-world study in China

Jianlin Xu, Bo Jin, Tianqing Chu et al. · Lung Cancer · 2016 · 94 citations

Medicine, Oncology, Pharmacology +15

Ethnicity and Migration as Determinants of Human Prostate Size*

Bo Jin, Leo Turner, Zehong Zhou et al. · The Journal of Clinical Endocrinology & Metabolism · 1999 · 78 citations · Full text

Medicine, Endocrinology, Urology +10

Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trial

Mengzhao Wang, Yun Fan, Meili Sun et al. · The Lancet Respiratory Medicine · 2023 · 66 citations

Medicine, Oncology, Pharmacology +12